DNA methylation screening identifies driver epigenetic events of cancer cell survival

Cancer Cell. 2012 May 15;21(5):655-667. doi: 10.1016/j.ccr.2012.03.045.

Abstract

Cancer cells typically exhibit aberrant DNA methylation patterns that can drive malignant transformation. Whether cancer cells are dependent on these abnormal epigenetic modifications remains elusive. We used experimental and bioinformatic approaches to unveil genomic regions that require DNA methylation for survival of cancer cells. First, we surveyed the residual DNA methylation profiles in cancer cells with highly impaired DNA methyltransferases. Then, we clustered these profiles according to their DNA methylation status in primary normal and tumor tissues. Finally, we used gene expression meta-analysis to identify regions that are dependent on DNA methylation-mediated gene silencing. We further showed experimentally that these genes must be silenced by DNA methylation for cancer cell survival, suggesting these are key epigenetic events associated with tumorigenesis.

Publication types

  • Meta-Analysis
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cell Death
  • Cell Survival
  • Cell Transformation, Neoplastic / genetics*
  • Cell Transformation, Neoplastic / metabolism
  • Cell Transformation, Neoplastic / pathology
  • Cluster Analysis
  • Computational Biology
  • DNA Methylation*
  • DNA Modification Methylases / genetics
  • DNA Modification Methylases / metabolism
  • Epigenesis, Genetic*
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Genetic Predisposition to Disease
  • HCT116 Cells
  • Humans
  • Neoplasms / enzymology
  • Neoplasms / genetics*
  • Neoplasms / pathology
  • Phenotype
  • RNA Interference
  • Reproducibility of Results
  • Time Factors
  • Transfection

Substances

  • DNA Modification Methylases

Associated data

  • GEO/GSE36534